UNSPSC 51393103: Guanoxabenz

This classification denotes an alpha-adrenergic agonist with the molecular formula C8H8Cl2N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P9HIK5V7WK, chemically known as 1-((2,6-dichlorobenzylidene)amino)-3-hydroxyguanidine but generally known as guanoxabenz, which bears US NIH Compound Identifier 9567831. European Medicines Agency schedules Guanoxabenz in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14038MIG.

UNSPSC 51393103 Guanoxabenz is a Commodity code that in practice encompasses pharmaceutical products and drug-related emergency-response supplies procured by state and local health and safety agencies. The recent solicitation record shows state and local governments buying naloxone and drug deactivation systems for community health and opioid-response initiatives, often through fixed-price competitive bidding with quarterly or regular delivery schedules. Issuing bodies include county health departments and community health programs operating under county administration. Vendors typically must demonstrate E-Verify compliance, drug-free workplace certification, and appropriate liability and workers' compensation insurance; some procurements carry federal funding and compliance requirements tied to FEMA or other federal sources.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, and quarterly delivery to the Seminole County Community Health Building in Sanford. The contract included a two-year initial term with a one-year renewal option and was potentially funded through FEMA. The source contains a single representative recent opportunity; broader geographic and issuing-body patterns are not supported by the available records.